RFJFHR51–Secukinumab monoclonal antibody drug. Targets interleukin-17A (IL-17A) and is used in treatment of psoriasis. Generic name and stylized antibody.
RF2F97XY9–Vidofludimus drug molecule, illustration
RF2GD76FF–Vidofludimus drug molecule (DHODH inhibitor). 3D rendering.
RFJFHR3R–Secukinumab monoclonal antibody drug. Targets interleukin-17A (IL-17A) and is used in treatment of psoriasis. Generic name and stylized antibody.
RF2GD76FT–Vidofludimus drug molecule (DHODH inhibitor). 3D rendering.
RFPKHKJ6–Secukinumab monoclonal antibody drug. Targets interleukin-17A (IL-17A) and is used in treatment of psoriasis. Generic name and stylized antibody repre
RFJ3P8NK–Interleukin 17 (IL-17A, IL-17) cytokine molecule. IL-17 antibodies are evaluated for the treatment of psoriasis and other diseases. Cartoon + line mod
RF2GD76FR–Vidofludimus drug molecule (DHODH inhibitor). 3D rendering.
RFJ3P8MJ–Interleukin 17 (IL-17A, IL-17) cytokine molecule. IL-17 antibodies are evaluated for the treatment of psoriasis and other diseases. Atoms shown as col
RFJ3P8MG–Interleukin 17 (IL-17A, IL-17) cytokine molecule. IL-17 antibodies are evaluated for the treatment of psoriasis and other diseases. Cartoon model + se
RFJ3KDB6–Interleukin 17 (IL-17A, IL-17) cytokine molecule. IL-17 antibodies are evaluated for the treatment of psoriasis and other diseases. Cartoon + line mod
RFJ3KDBA–Interleukin 17 (IL-17A, IL-17, dimer) cytokine molecule. IL-17 antibodies are evaluated for the treatment of psoriasis and other diseases. Cartoon mod
RFJ3P8N7–Interleukin 17 (IL-17A, IL-17) cytokine molecule. IL-17 antibodies are evaluated for the treatment of psoriasis and other diseases. Atoms shown as col
RFJ3KDB4–Interleukin 17 (IL-17A, IL-17) cytokine molecule. IL-17 antibodies are evaluated for the treatment of psoriasis and other diseases. Atoms shown as col
RFJFHPCY–Ixekizumab monoclonal antibody drug. Targets interleukin 17 (IL-17); indicated for treatment of plaque psoriasis. Generic name and stylized antibody.
RFJFHPDF–Ixekizumab monoclonal antibody drug. Targets interleukin 17 (IL-17); indicated for treatment of plaque psoriasis. Generic name and stylized antibody.
RFPKHKEW–Ixekizumab monoclonal antibody drug. Targets interleukin 17 (IL-17); indicated for treatment of plaque psoriasis. Generic name and stylized antibody r
RF2CBNRFM–Vidofludimus drug molecule (DHODH inhibitor). Skeletal formula.
RF2HFGJR6–Vidofludimus drug molecule (DHODH inhibitor). Skeletal formula.
RF2HFGPJX–Vidofludimus drug molecule (DHODH inhibitor). Skeletal formula.
RF2CCFM12–Vidofludimus drug molecule (DHODH inhibitor). 3D rendering. Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon
RF2CCFM0N–Vidofludimus drug molecule (DHODH inhibitor). 3D rendering. Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon
RF2CCFM15–Vidofludimus drug molecule (DHODH inhibitor). 3D rendering. Atoms are represented as spheres with conventional color coding: hydrogen (white), carbon
Download Confirmation
Please complete the form below. The information provided will be included in your download confirmation